35D

1-[4-(3-{[1-(quinolin-2-yl)azetidin-3-yl]oxy}quinoxalin-2-yl)piperidin-1-yl]ethanone

Created:	2014-06-18
Last modified:	2014-12-17

Find Related PDB Entry
1 entries where 35D is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	61
Chiral Atom Count	0
Bond Count	66
Aromatic Bond Count	22

2D diagram of 35D

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	1-[4-(3-{[1-(quinolin-2-yl)azetidin-3-yl]oxy}quinoxalin-2-yl)piperidin-1-yl]ethanone
Systematic Name (OpenEye OEToolkits)	1-[4-[3-(1-quinolin-2-ylazetidin-3-yl)oxyquinoxalin-2-yl]piperidin-1-yl]ethanone
Formula	C₂₇ H₂₇ N₅ O₂
Molecular Weight	453.536
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C(N6CCC(c4nc5c(nc4OC3CN(c1nc2c(cc1)cccc2)C3)cccc5)CC6)C
SMILES	CACTVS	3.385	CC(=O)N1CCC(CC1)c2nc3ccccc3nc2OC4CN(C4)c5ccc6ccccc6n5
SMILES	OpenEye OEToolkits	1.9.2	CC(=O)N1CCC(CC1)c2c(nc3ccccc3n2)OC4CN(C4)c5ccc6ccccc6n5
Canonical SMILES	CACTVS	3.385	CC(=O)N1CCC(CC1)c2nc3ccccc3nc2OC4CN(C4)c5ccc6ccccc6n5
Canonical SMILES	OpenEye OEToolkits	1.9.2	CC(=O)N1CCC(CC1)c2c(nc3ccccc3n2)OC4CN(C4)c5ccc6ccccc6n5
InChI	InChI	1.03	InChI=1S/C27H27N5O2/c1-18(33)31-14-12-20(13-15-31)26-27(30-24-9-5-4-8-23(24)29-26)34-21-16-32(17-21)25-11-10-19-6-2-3-7-22(19)28-25/h2-11,20-21H,12-17H2,1H3
InChIKey	InChI	1.03	VSJCZYGHEFDAJZ-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
Pharos	CHEMBL3356684
PubChem	58547814
ChEMBL	CHEMBL3356684

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.